__NUXT_JSONP__("/drugs/2-Deoxy-D-glucose", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"154-17-6",chebiId:b,chemicalFormula:b,definition:"A non-metabolizable glucose analog in which the hydroxyl group at position 2 of glucose is replaced by hydrogen, with potential glycolysis inhibiting and antineoplastic activities. Although the exact mechanism of action has yet to be fully elucidated, upon administration of 2-deoxy-D-glucose (2-DG), this agent competes with glucose for uptake by proliferating cells, such as tumor cells. 2-DG inhibits the first step of glycolysis and therefore prevents cellular energy production, which may result in decreased tumor cell proliferation.",fdaUniiCode:"9G2MP84A8W",identifier:"C116618",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C344"],synonyms:["2-DEOXYGLUCOSE","2-DG",a,"Deoxyglucose"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002F2-Deoxy-D-glucose",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("2-Deoxy-D-glucose","","2021-10-30T13:19:08.523Z")));